Abstract
Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have